General Information of Drug Off-Target (DOT) (ID: OTM36JXE)

DOT Name Phosphatidylcholine transfer protein (PCTP)
Synonyms PC-TP; START domain-containing protein 2; StARD2; StAR-related lipid transfer protein 2
Gene Name PCTP
Related Disease
Cholestasis ( )
Fatty liver disease ( )
Gestational trophoblastic neoplasia ( )
Type-1/2 diabetes ( )
UniProt ID
PPCT_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
1LN1; 1LN2; 1LN3; 7U9D
Pfam ID
PF01852
Sequence
MELAAGSFSEEQFWEACAELQQPALAGADWQLLVETSGISIYRLLDKKTGLYEYKVFGVL
EDCSPTLLADIYMDSDYRKQWDQYVKELYEQECNGETVVYWEVKYPFPMSNRDYVYLRQR
RDLDMEGRKIHVILARSTSMPQLGERSGVIRVKQYKQSLAIESDGKKGSKVFMYYFDNPG
GQIPSWLINWAAKNGVPNFLKDMARACQNYLKKT
Function Catalyzes the transfer of phosphatidylcholine between membranes. Binds a single lipid molecule.
Tissue Specificity Highest expression in liver, placenta, testis, kidney and heart. Low levels in brain and lung. No expression detected in thymus.
Reactome Pathway
Mitochondrial Fatty Acid Beta-Oxidation (R-HSA-77289 )
Synthesis of PC (R-HSA-1483191 )

Molecular Interaction Atlas (MIA) of This DOT

4 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Cholestasis DISDJJWE Strong Altered Expression [1]
Fatty liver disease DIS485QZ Strong Biomarker [2]
Gestational trophoblastic neoplasia DIS4EJNA Strong Altered Expression [3]
Type-1/2 diabetes DISIUHAP Limited Biomarker [4]
------------------------------------------------------------------------------------
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
14 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the expression of Phosphatidylcholine transfer protein (PCTP). [5]
Ciclosporin DMAZJFX Approved Ciclosporin decreases the expression of Phosphatidylcholine transfer protein (PCTP). [6]
Tretinoin DM49DUI Approved Tretinoin increases the expression of Phosphatidylcholine transfer protein (PCTP). [7]
Doxorubicin DMVP5YE Approved Doxorubicin decreases the expression of Phosphatidylcholine transfer protein (PCTP). [8]
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate decreases the expression of Phosphatidylcholine transfer protein (PCTP). [9]
Cisplatin DMRHGI9 Approved Cisplatin increases the expression of Phosphatidylcholine transfer protein (PCTP). [10]
Calcitriol DM8ZVJ7 Approved Calcitriol increases the expression of Phosphatidylcholine transfer protein (PCTP). [11]
Testosterone DM7HUNW Approved Testosterone increases the expression of Phosphatidylcholine transfer protein (PCTP). [11]
Phenobarbital DMXZOCG Approved Phenobarbital affects the expression of Phosphatidylcholine transfer protein (PCTP). [12]
Isotretinoin DM4QTBN Approved Isotretinoin decreases the expression of Phosphatidylcholine transfer protein (PCTP). [13]
Sodium lauryl sulfate DMLJ634 Approved Sodium lauryl sulfate increases the expression of Phosphatidylcholine transfer protein (PCTP). [14]
Capsaicin DMGMF6V Approved Capsaicin decreases the expression of Phosphatidylcholine transfer protein (PCTP). [15]
Dihydrotestosterone DM3S8XC Phase 4 Dihydrotestosterone increases the expression of Phosphatidylcholine transfer protein (PCTP). [17]
Coumestrol DM40TBU Investigative Coumestrol decreases the expression of Phosphatidylcholine transfer protein (PCTP). [19]
------------------------------------------------------------------------------------
⏷ Show the Full List of 14 Drug(s)
1 Drug(s) Affected the Protein Interaction/Cellular Processes of This DOT
Drug Name Drug ID Highest Status Interaction REF
Clofibrate DMPC1J7 Approved Clofibrate affects the localization of Phosphatidylcholine transfer protein (PCTP). [16]
------------------------------------------------------------------------------------
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the methylation of Phosphatidylcholine transfer protein (PCTP). [18]
------------------------------------------------------------------------------------

References

1 Etiologic significance of defects in cholesterol, phospholipid, and bile acid metabolism in the liver of patients with intrahepatic calculi.Hepatology. 2001 May;33(5):1194-205. doi: 10.1053/jhep.2001.23936.
2 Phosphatidylcholine transfer protein/StarD2 promotes microvesicular steatosis and liver injury in murine experimental steatohepatitis.Am J Physiol Gastrointest Liver Physiol. 2017 Jul 1;313(1):G50-G61. doi: 10.1152/ajpgi.00379.2016. Epub 2017 Apr 6.
3 GTT1/StarD7, a novel phosphatidylcholine transfer protein-like highly expressed in gestational trophoblastic tumour: cloning and characterization.Placenta. 2004 Jan;25(1):37-44. doi: 10.1016/S0143-4004(03)00214-5.
4 Genetic ablation of phosphatidylcholine transfer protein/StarD2 in ob/ob mice improves glucose tolerance without increasing energy expenditure.Metabolism. 2017 Mar;68:145-149. doi: 10.1016/j.metabol.2016.11.012. Epub 2016 Dec 1.
5 Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
6 Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci. 2010 May;115(1):66-79.
7 Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. Cells. 2020 Nov 5;9(11):2423. doi: 10.3390/cells9112423.
8 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
9 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
10 Low doses of cisplatin induce gene alterations, cell cycle arrest, and apoptosis in human promyelocytic leukemia cells. Biomark Insights. 2016 Aug 24;11:113-21.
11 Effects of 1alpha,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells. Mol Cancer. 2011 May 18;10:58.
12 Reproducible chemical-induced changes in gene expression profiles in human hepatoma HepaRG cells under various experimental conditions. Toxicol In Vitro. 2009 Apr;23(3):466-75. doi: 10.1016/j.tiv.2008.12.018. Epub 2008 Dec 30.
13 Temporal changes in gene expression in the skin of patients treated with isotretinoin provide insight into its mechanism of action. Dermatoendocrinol. 2009 May;1(3):177-87.
14 CXCL14 downregulation in human keratinocytes is a potential biomarker for a novel in vitro skin sensitization test. Toxicol Appl Pharmacol. 2020 Jan 1;386:114828. doi: 10.1016/j.taap.2019.114828. Epub 2019 Nov 14.
15 Induction of the endoplasmic reticulum stress protein GADD153/CHOP by capsaicin in prostate PC-3 cells: a microarray study. Biochem Biophys Res Commun. 2008 Aug 8;372(4):785-91.
16 Clofibrate-induced relocation of phosphatidylcholine transfer protein to mitochondria in endothelial cells. Exp Cell Res. 2002 Mar 10;274(1):100-11. doi: 10.1006/excr.2001.5460.
17 LSD1 activates a lethal prostate cancer gene network independently of its demethylase function. Proc Natl Acad Sci U S A. 2018 May 1;115(18):E4179-E4188.
18 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
19 Pleiotropic combinatorial transcriptomes of human breast cancer cells exposed to mixtures of dietary phytoestrogens. Food Chem Toxicol. 2009 Apr;47(4):787-95.